Innovative Targeting Solutions GPCR Pipeline Profiled in Nature Biopharma Dealmakers
September 1, 2014
Burnaby, B.C., Canada. September 1st, 2014: Read Innovative Targeting Solutions Biopharma Dealmakers Profile here: Innovative-Targeting-Nature-Sep2014
About Innovative Targeting Solutions Inc. Founded in 2008, Innovative Targeting Solutions Inc. is a privately‐held company that has developed the HuTARG technology a next generation protein engineering platform for the generation and maturation of fully human antibody therapeutics. The HuTARG technology is a fully mammalian technology that generates antibody diversity in vitro via RAG1/RAG2 mediated V(D)J recombination. For more information please visit www.innovativetargeting.com